Aminohippurate sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for aminohippurate sodium and what is the scope of patent protection?
Aminohippurate sodium
is the generic ingredient in one branded drug marketed by Merck and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for aminohippurate sodium
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 194 |
Clinical Trials: | 6 |
Patent Applications: | 1,750 |
Formulation / Manufacturing: | see details |
DailyMed Link: | aminohippurate sodium at DailyMed |
Recent Clinical Trials for aminohippurate sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
M.H.H. Kramer | Phase 4 |
AstraZeneca | Phase 4 |
Brigham and Women's Hospital | Phase 2 |
US Patents and Regulatory Information for aminohippurate sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | AMINOHIPPURATE SODIUM | aminohippurate sodium | INJECTABLE;INJECTION | 005619-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |